Stefano Scafuri

Dr. Stefano Scafuri


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Cardiovascular Computed Tomography
Verified
Journal Article
Closed access
Gianluca PontoneGianluca Pontone
Gianluca Pontone
SSStefano Scafuri
Stefano Scafuri
MMMaria Elisabetta Mancini
Maria Elisabetta Mancini
CACecilia Agalbato
Cecilia Agalbato
MGMarco Guglielmo
Marco Guglielmo
ARAlexia Rossi
Alexia Rossi

1 June 2021 in Computer Methods and Programs in Biomedicine
Verified
Journal Article
Closed access
MPMarco Penso
Marco Penso
Sara MocciaSara Moccia
Sara Moccia
SSStefano Scafuri
Stefano Scafuri
GMGiuseppe Muscogiuri
Giuseppe Muscogiuri
Gianluca PontoneGianluca Pontone
Gianluca Pontone
Enrico Gianluca CaianiEnrico Gianluca Caiani
Enrico Gianluca Caiani

29 September 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
Andrea BaggianoAndrea Baggiano
Andrea Baggiano
ATAlberico Del Torto
Alberico Del Torto
Marco GuglielmoMarco Guglielmo
Marco Guglielmo
GMGiuseppe Muscogiuri
Giuseppe Muscogiuri
Laura FusiniLaura Fusini
Laura Fusini
Gianluca PontoneGianluca Pontone
Gianluca Pontone
Non-ischemic cardiomyopathies represent a heterogeneous group of myocardial diseases potentially leading to heart failure, life-threatening arrhythmias, and eventually death. Myocardial dysfunction is associated with different underlying pathological processes, ultimately inducing changes in morphological appearance. Thus, classification based on presenting morphological phenotypes has been proposed, i.e., dilated, hypertrophic, restrictive, and right ventricular cardiomyopathies. In light of the key diagnostic and prognostic role of morphological and functional features, cardiovascular imaging has emerged as key element in the clinical workflow of suspected cardiomyopathies, and above all, cardiovascular magnetic resonance (CMR) represents the ideal technique to be used: thanks to its physical principles, besides optimal spatial and temporal resolutions, incomparable contrast resolution allows to assess myocardial tissue abnormalities in detail. Traditionally, weighted images and late enhancement images after gadolinium-based contrast agent administration have been used to perform tissue characterization, but in the last decade quantitative assessment of pre-contrast longitudinal relaxation time (native T1), post-contrast longitudinal relaxation time (post-contrast T1) and transversal relaxation time (T2), all displayed with dedicated pixel-wise color-coded maps (mapping), has contributed to give precious knowledge insight, with positive influence of diagnostic accuracy and prognosis assessment, mostly in the setting of the hypertrophic phenotype. This review aims to describe the available evidence of the role of mapping techniques in the assessment of hypertrophic phenotype, and to suggest their integration in the routine CMR evaluation of newly diagnosed cardiomyopathies with increased wall thickness.

15 January 2021 in BioMed Research International
Verified
Journal Article
Open access
PDF file
Francesca BaessatoFrancesca Baessato
Francesca Baessato
Marco GuglielmoMarco Guglielmo
Marco Guglielmo
GMGiuseppe Muscogiuri
Giuseppe Muscogiuri
Andrea BaggianoAndrea Baggiano
Andrea Baggiano
Laura FusiniLaura Fusini
Laura Fusini
Gianluca PontoneGianluca Pontone
Gianluca Pontone
The recently published 2019 guidelines on chronic coronary syndromes (CCS) focus on the need for noninvasive imaging modalities to accurately establish the diagnosis of coronary artery disease (CAD) and assess the risk of clinical scenario occurrence. Appropriate patient management should rely on controlling symptoms, improving prognosis, and guiding each therapeutic strategy as well as monitoring disease progress. Among the noninvasive imaging modalities, cardiovascular magnetic resonance (CMR) has gained broad acceptance in past years due to its unique features in providing a complete assessment of CAD through data on cardiac anatomy and function and myocardial viability, with high spatial and temporal resolution and without ionizing radiation. In detail, evaluation of the presence and extent of myocardial ischemia through stress CMR (S‐CMR) has shown a high rule‐in power in detecting functionally significant coronary artery stenosis in patients suspected of CCS. Moreover, S‐CMR technique may add significant prognostic value, as demonstrated by different studies which have progressively evidenced the valuable power of this multiparametric imaging modality in predicting adverse cardiac events. The latest scientific progress supports a greater expansion of S‐CMR with improvement of quantitative myocardial perfusion analysis, myocardial strain, and native mapping within the same examination. Although further study is warranted, these techniques, which are currently mostly restricted to the research field, are likely to become increasingly prevalent in the clinical setting with the scope of increasing accuracy in the selection of patients to be sent to invasive revascularization. This review investigates the diagnostic and prognostic role of S‐CMR in the context of CAD, by analysing a strong, long‐standing, scientific evidence together with an appraisal of new advanced techniques which may potentially enrich CAD management in the next future.